Obstetrics & Gynecology

News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Antifungal Therapy Shows Potential for IBD Patients with Candida Overgrowth

3D illustration of fungi Candida albicans

A commonly used systemic antifungal medication may help reduce symptoms in a subset of patients with inflammatory bowel disease (IBD) by restoring a healthier gut microbiome, according to a preliminary study by Weill Cornell Medicine investigators. 

headshot of a man

Dr. Iliyan Iliev

The study, published Sept.1 in Nature Medicine, provides what is thought to be the first evidence that targeting intestinal fungal dysbiosis can reshape bacterial and fungal microbiome dynamics in patients with IBD and establishes a framework for mycobiome-guided precision therapies. It compared the effects of two weeks of treatment with the antifungal mouthwash nystatin or the systemic antifungal medication fluconazole in 53 patients already receiving standard therapies for mild to moderate IBD who had an oral fungal infection called thrush.

Model Helps Scientists Build Better Protein-Degrading Therapies

cartoon showing old and new approaches to blocking proteins

A team of Weill Cornell Medicine investigators has developed a computer model that will help scientists more efficiently develop protein-destroying therapies, a newer type of treatment that is particularly promising for cancer. The study was published July 13 in Nature Communications.

Most drugs use a small molecule to render disease-causing proteins harmless, but protein-degrader therapies aim to destroy the target protein altogether. Eliminating proteins, for example, those with cancer-causing mutations, or proteins produced in harmful excess quantities may offer advantages over disabling a protein. The new model could potentially shave years off the process of developing a new protein degrader therapy.

Dr. Olivier Elemento

Dr. Olivier Elemento

How Will AI Impact the Future of the Clinical Workforce?

photo of the legs of people wearing scrubs walking in a hallway

Contrary to some predictions, the use of artificial intelligence (AI) agents could lead to more, not fewer, health care professionals working in the United States, according to a new article by a physician and health policy researcher at Weill Cornell Medicine who surveyed economic theory and the history of technology in health care.

Dr. Dhruv Khullar

Dr. Dhruv Khullar

Contact Us